{'fraction_non_alphanumeric': 0.012048192771084338, 'fraction_numerical': 0.0, 'mean_word_length': 4.973856209150327, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Clinical Evaluation in the Normative Aging Study

Life expectancy is determined by disease development and the process of aging. Much is known about the significance of control of disease to the length of life, and changes in life expectancy have largely been the result of this disease control. Further alteration in the length of life will be greatly dependent on control of the aging process. Little is known about the biochemistry, physiology, genetic, environmental and other factors involved in aging as they relate to the human subject in a clinical setting. The Normative Aging Study is attempting to improve our definition of the clinical aging process. Through the prospective evaluation of a population previously determined to be normal the various factors resulting in aging may be described. Once recognized it is hoped that alteration of these factors might allow some control of the aging process.